-transparent.png){kind=logo}
In the last two decades, there has been rapid progress in the pharmacologic treatment of affective disorders. In Part I of this review, drugs mainly used for depression (tricyclic antidepressants and monoamine oxidase inhibitors) were discussed. Here, lithium carbonate, the most effective drug for manic-depressive illness (bipolar depression) is the focus. Its indications, mode of action, pharmacokinetics, dosage, and side effects are discussed. A section on drug interactions with lithium deals with the combination effect of lithium used with antidepressant and other psychotropic agents.
Related Publications
A H Rosenbaum, and
T Maruta, and
E Richelson
September 1990,
Pharmacological reviews,
A H Rosenbaum, and
T Maruta, and
E Richelson
June 1981,
Mayo Clinic proceedings,
A H Rosenbaum, and
T Maruta, and
E Richelson
January 1980,
Mayo Clinic proceedings,
A H Rosenbaum, and
T Maruta, and
E Richelson
February 1993,
Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates,
A H Rosenbaum, and
T Maruta, and
E Richelson
August 1979,
Mayo Clinic proceedings,
A H Rosenbaum, and
T Maruta, and
E Richelson
March 1993,
Primary care,
A H Rosenbaum, and
T Maruta, and
E Richelson
June 1980,
Mayo Clinic proceedings,
A H Rosenbaum, and
T Maruta, and
E Richelson
January 1988,
The Veterinary clinics of North America. Small animal practice,
A H Rosenbaum, and
T Maruta, and
E Richelson
December 1980,
Mayo Clinic proceedings,
A H Rosenbaum, and
T Maruta, and
E Richelson
August 1989,
Journal of the American Academy of Dermatology,
